The Safety of Oral Apixaban (Eliquis) Versus Subcutaneous Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy; a Prospective Randomized Open Blinded End-point (PROBE) Design
Phase of Trial: Phase II
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Apixaban (Primary) ; Enoxaparin sodium
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 24 Oct 2017 Planned number of patients changed from 171 to 400.
- 01 May 2017 Planned number of patients changed from 400 to 171.
- 01 May 2017 Planned End Date changed from 1 Jun 2018 to 1 Mar 2018.